Content Details
H.R. 5382 (IH) - To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.
Loading...
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
U.S. Congress. House. To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices. H.R. 5382. 116th Cong., 1st sess., Introduced in House December 10, 2019. https://www.govinfo.gov/app/details/BILLS-116hr5382ih.
Congress, House of Representatives (2019, December 10). To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices. (H.R. 5382 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-116hr5382ih.
United States, Congress, House of Representatives. To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-116hr5382ih. 116th Congress, H.R. 5382, Introduced in House 10 Dec. 2019.
H.R.5382 - 116th Congress (2019-2020): To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices., H.R.5382, 116th Cong. (2019), https://www.govinfo.gov/app/details/BILLS-116hr5382ih.